PMID: 22340066īrotto, L, Erskine Y, Carey M, Ehlen T, Finlayson S, Heywood M, Kwon J, Thomson S, Stuart G, McAlpine JN, Miller DM. Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study. PMID: 21707717īrotto L, Branco N, Dunkley C, McCullum M, McAlpine JN. Human epidermal growth factor receptor 2 overexpression and amplification in mucinous tumours of ovary Histopathology, 2011 Jun 58(7):1173-4. Survivorship as an element of clinical trials in ovarian cancer. Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection. McAlpine JN, El-Hallani S, Lam SF, Kalloger SE Luk M, Huntsman DG, MacAulay, C, Gilks CB, Miller DM, Lane PM. Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts. Kortman U, McAlpine JN, Xue H, Guan J, Ha G, Tully S, Shafait S, Lau A, Cranston AN, O’Conner MJ, Huntsman DG, Wang Y, Gilks CB. HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.

McAlpine JN, Wiegand KC, Vang R, Ronnett BM, Adamiak AK.

Jessica panzarella